Sirt3‐dependent deacetylation of COX‐1 counteracts oxidative stress‐induced cell apoptosis

The mitochondrial complexes are prone to sirtuin (Sirt)3‐mediated deacetylation modification, which may determine cellular response to stimuli, such as oxidative stress. In this study, we show that the cytochrome c oxidase (COX)‐1, a core catalytic subunit of mitochondrial complex IV, was acetylated and deactivated both in 2, 2'‐azobis(2‐amidinopropane) dihydrochloride‐treated NIH/3T3 cells and hydrogen peroxide‐treated primary neuronal cells, correlating with apoptotic cell death induction by oxidative stress. Inhibition of Sirt3 by small interfering RNA or the inhibitor nicotinamide induced accumulation of acetylation of COX‐1, reduced mitochondrial membrane potential, and increased cell apoptosis. In contrast, overexpression of Sirt3 enhanced deacetylation of COX‐1 and inhibited oxidative stress‐induced apoptotic cell death. Significantly, rats treated with ischemia/reperfusion injury, a typical oxidative stress‐related disease, presented an inhibition of Sirt3‐induced hyperacetylation of COX‐1 in the brain tissues. Furthermore, K13, K264, K319, and K481 were identified as the acetylation sits of COX‐1 in response to oxidative stress. In conclusion, COX‐1 was discovered as a new deacetylation target of Sirt3, indicating that the Sirt3/COX‐1 axis is a promising therapy target of stress‐related diseases.—Tu, L.‐F., Cao, L.‐F., Zhang Y.‐H., Guo, Y.‐L., Zhou, Y.‐F., Lu, W.‐Q., Zhang, T.‐Z., Zhang, T., Zhang, G.‐X., Kurihara, H., Li, Y.‐F., He, R.‐R. Sirt3‐dependent deacetylation of COX‐1 counteracts oxidative stress‐induced cell apoptosis. FASEB J. 33, 14118‐14128 (2019). www.fasebj.org

[1]  X. Yang,et al.  Sirt3 Mediates the Inhibitory Effect of Adjudin on Astrocyte Activation and Glial Scar Formation following Ischemic Stroke , 2017, Front. Pharmacol..

[2]  M. Carrì,et al.  SIRT3 and mitochondrial metabolism in neurodegenerative diseases , 2017, Neurochemistry International.

[3]  Xiaobo B Han,et al.  ROS-Dependent Activation of Autophagy through the PI3K/Akt/mTOR Pathway Is Induced by Hydroxysafflor Yellow A-Sonodynamic Therapy in THP-1 Macrophages , 2017, Oxidative medicine and cellular longevity.

[4]  Yi-dong Wang,et al.  SIRT3 in cardiovascular diseases: Emerging roles and therapeutic implications. , 2016, International journal of cardiology.

[5]  Md. Shahedur Rahman,et al.  Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease , 2016, Aging cell.

[6]  Yubo Xiao,et al.  The defensive effect of phellodendrine against AAPH-induced oxidative stress through regulating the AKT/NF-κB pathway in zebrafish embryos. , 2016, Life sciences.

[7]  Qi Wang,et al.  A SIRT3/AMPK/autophagy network orchestrates the protective effects of trans-resveratrol in stressed peritoneal macrophages and RAW 264.7 macrophages. , 2016, Free radical biology & medicine.

[8]  Mark P Mattson,et al.  Mitochondrial SIRT3 Mediates Adaptive Responses of Neurons to Exercise and Metabolic and Excitatory Challenges. , 2016, Cell metabolism.

[9]  Brett S. Peterson,et al.  SIRT3 regulates progression and development of diseases of aging , 2015, Trends in Endocrinology & Metabolism.

[10]  R. Wiesner,et al.  Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6 , 2015, Cell Death and Disease.

[11]  S. Sollott,et al.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.

[12]  R. Korthuis,et al.  Mitochondrial reactive oxygen species: A double edged sword in ischemia/reperfusion vs preconditioning , 2014, Redox biology.

[13]  R. Patel,et al.  Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress , 2013, Cell Death and Disease.

[14]  M. Haigis,et al.  SIRT3 regulation of mitochondrial oxidative stress , 2013, Experimental Gerontology.

[15]  Sean D. Mooney,et al.  Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways , 2013, Proceedings of the National Academy of Sciences.

[16]  Xuesong Yang,et al.  A New Oxidative Stress Model, 2,2-Azobis(2-Amidinopropane) Dihydrochloride Induces Cardiovascular Damages in Chicken Embryo , 2013, PloS one.

[17]  Jyothi Arikkath,et al.  Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex , 2012, Nature Protocols.

[18]  Liang Wang,et al.  Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models , 2012, Journal of neuroscience research.

[19]  M. Hüttemann,et al.  Multiple phosphorylations of cytochrome c oxidase and their functions , 2012, Proteomics.

[20]  J. Denu,et al.  SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status*♦ , 2012, The Journal of Biological Chemistry.

[21]  J. Joseph,et al.  Additive Effects of Mitochondrion-targeted Cytochrome CYP2E1 and Alcohol Toxicity on Cytochrome c Oxidase Function and Stability of Respirosome Complexes* , 2012, The Journal of Biological Chemistry.

[22]  Yuqi Ren,et al.  Effect of Suture Properties on Stability of Middle Cerebral Artery Occlusion Evaluated by Synchrotron Radiation Angiography , 2012, Stroke.

[23]  Robert V Farese,et al.  SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. , 2011, Molecular cell.

[24]  S. Gygi,et al.  Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity , 2011, PloS one.

[25]  P. Pagliaro,et al.  Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. , 2011, World journal of cardiology.

[26]  L. Guarente,et al.  SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production , 2011, Oncogene.

[27]  Q. Tong,et al.  Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. , 2010, Biochemistry.

[28]  C. Deng,et al.  SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. , 2010, Cancer cell.

[29]  S. Vatner,et al.  Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction. , 2009, American journal of physiology. Cell physiology.

[30]  Gene Kim,et al.  Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. , 2009, The Journal of clinical investigation.

[31]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[32]  D. Aggarwal,et al.  Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. , 2009, Biophysical journal.

[33]  Shiwei Song,et al.  A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis , 2008, Proceedings of the National Academy of Sciences.

[34]  D. Galati,et al.  Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion , 2007, FEBS letters.

[35]  Robin A. J. Smith,et al.  Targeting an antioxidant to mitochondria decreases cardiac ischemia‐reperfusion injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  S. Ficarro,et al.  cAMP-dependent Tyrosine Phosphorylation of Subunit I Inhibits Cytochrome c Oxidase Activity* , 2005, Journal of Biological Chemistry.

[37]  Icksoo Lee,et al.  The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. , 2004, Biochimica et biophysica acta.

[38]  P. Hersey,et al.  How melanoma cells evade trail-induced apoptosis , 2001, Nature Reviews Cancer.

[39]  A. Shah,et al.  Mitochondrial dysfunction and oxidative stress in CHF , 2014 .